Treace Medical Concepts Securities Lawsuit
Analysis based on 6 articles · First reported May 16, 2025 · Last updated Jun 06, 2025
The market is impacted by the significant drop in Treace Medical Concepts' stock price, which fell nearly 63% due to lowered revenue guidance and increased competition. This event highlights the risks associated with investing in companies facing product competition and potential securities law violations.
Faruqi & Faruqi, LLP is investigating Treace Medical Concepts, Inc. for potential federal securities law violations and has filed a class action lawsuit. The complaint alleges that Treace Medical Concepts made false and misleading statements regarding its business, operations, and prospects, specifically concerning competition impacting its Lapiplasty 3D Bunion Correction System. On May 7, 2024, Treace Medical Concepts lowered its full-year 2024 revenue guidance and revealed competition from minimally invasive osteotomy and Lapiplasty 'knockoffs'. This news caused Treace Medical Concepts' stock price to fall by nearly 63% on May 8, 2024. Investors who suffered losses are encouraged to contact Faruqi & Faruqi to discuss their legal rights, with a deadline of June 10, 2025, to seek the role of lead plaintiff.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard